SG Americas Securities LLC Has $526,000 Stake in The Clorox Company (NYSE:CLX)

SG Americas Securities LLC reduced its stake in The Clorox Company (NYSE:CLX - Free Report) by 96.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,575 shares of the company's stock after selling 111,677 shares during the period. SG Americas Securities LLC's holdings in Clorox were worth $526,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in CLX. Redwood Park Advisors LLC acquired a new stake in shares of Clorox in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox in the 4th quarter worth approximately $31,000. Wood Tarver Financial Group LLC bought a new stake in shares of Clorox in the 4th quarter worth approximately $31,000. GKV Capital Management Co. Inc. bought a new stake in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Clorox in the 4th quarter worth approximately $33,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the topic of a number of research reports. Barclays dropped their target price on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. Wells Fargo & Company dropped their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Morgan Stanley cut their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Finally, Citigroup cut their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, Clorox currently has a consensus rating of "Hold" and a consensus price target of $151.23.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.57% of the company's stock.

Clorox Price Performance

Shares of CLX stock traded down $0.22 during mid-day trading on Tuesday, reaching $122.08. The company's stock had a trading volume of 1,380,582 shares, compared to its average volume of 1,363,839. The Clorox Company has a 1-year low of $120.33 and a 1-year high of $171.37. The company has a market cap of $15.05 billion, a P/E ratio of 21.92, a PEG ratio of 2.77 and a beta of 0.54. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The firm's 50-day moving average is $132.74 and its two-hundred day moving average is $146.30.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The company's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.71 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.